AspenBio Pharma (APPY) to Offer 4.48M Common at $1.70 Per Share
AspenBio Pharma, Inc. (Nasdaq: APPY) today announced that it has priced a public offering of 4,482,609 shares of its common stock at $1.70 per share. The approximately $7.2 million of net proceeds will be used for product development, FDA 510(k) submission related activities, general corporate purposes, and working capital.
The underwriter, ThinkEquity LLC, has been granted a 30-day option to purchase up to an additional 672,391 shares to cover over-allotments, if any.
The underwriter, ThinkEquity LLC, has been granted a 30-day option to purchase up to an additional 672,391 shares to cover over-allotments, if any.
You May Also Be Interested In
- Petroleum Development Corp (PETD) Closes 6.5M Offering at $26.50/Share
- Auxilium Pharma (AUXL), Glaxo (GSK) Enter Testim 1% Co-Promotion Agreement
- Yahoo! (YHOO) Sells Half of its Alibaba Stake for $7.1 Billion, Boosts Buyback Plan By $5 Billion
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
ThinkEquitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
